{"nct_id":"NCT02789345","title":"A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2016-10-24","start_date_type":"ACTUAL","primary_completion_date":"2017-10-19","primary_completion_date_type":"ACTUAL","completion_date":"2022-05-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}